Anti-Aging Biotech | Raising Capital to Extended Tomorrow

September 28, 2021

Fountain Therapeutics is a pre-clinical biotech leveraging deep learning and computer vision to discover and develop molecules which can impact age related diseases and potentially aging itself. After recently completing a successful Series A, led by Khosla Ventures, Fountain was tasked with identifying a new CEO with a proven track record raising significant money for…

Read More